94 related articles for article (PubMed ID: 29600984)
21. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool.
Luo JL; Yang Q; Tong WM; Hergenhahn M; Wang ZQ; Hollstein M
Oncogene; 2001 Jan; 20(3):320-8. PubMed ID: 11313961
[TBL] [Abstract][Full Text] [Related]
22. The genetics of the p53 pathway, apoptosis and cancer therapy.
Vazquez A; Bond EE; Levine AJ; Bond GL
Nat Rev Drug Discov; 2008 Dec; 7(12):979-87. PubMed ID: 19043449
[TBL] [Abstract][Full Text] [Related]
23. Role of Cdk1 in the p53-independent abrogation of the postmitotic checkpoint by human papillomavirus E6.
Zhang W; Liu Y; Zhao N; Chen H; Qiao L; Zhao W; Chen JJ
J Virol; 2015 Mar; 89(5):2553-62. PubMed ID: 25520504
[TBL] [Abstract][Full Text] [Related]
24. Expression of p53, MDM2, p21, heat shock protein 70, and HPV 16/18 E6 proteins in oral verrucous carcinoma and oral verrucous hyperplasia.
Lin HP; Wang YP; Chiang CP
Head Neck; 2011 Mar; 33(3):334-40. PubMed ID: 20583115
[TBL] [Abstract][Full Text] [Related]
25. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
Tokman B; Gultekin SE; Sezer C; Alpar R
Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
[TBL] [Abstract][Full Text] [Related]
26. MDM2-p53 pathway in hepatocellular carcinoma.
Meng X; Franklin DA; Dong J; Zhang Y
Cancer Res; 2014 Dec; 74(24):7161-7. PubMed ID: 25477334
[TBL] [Abstract][Full Text] [Related]
27. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
[TBL] [Abstract][Full Text] [Related]
28. Oligomerisation of full length p53 contributes to the interaction with mdm2 but not HPV E6.
Marston NJ; Jenkins JR; Vousden KH
Oncogene; 1995 May; 10(9):1709-15. PubMed ID: 7753547
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation.
Cheng YW; Wu MF; Wang J; Yeh KT; Goan YG; Chiou HL; Chen CY; Lee H
Cancer Res; 2007 Nov; 67(22):10686-93. PubMed ID: 18006810
[TBL] [Abstract][Full Text] [Related]
30. Degradation of HPV20E6 by p53: Delta Np63 alpha and mutant p53R248W protect the wild type p53 mediated caspase-degradation.
Fei JW; de Villiers EM
Int J Cancer; 2008 Jul; 123(1):108-16. PubMed ID: 18412244
[TBL] [Abstract][Full Text] [Related]
31. Pathological features of betel quid-related oral epithelial lesions in taiwan with special emphasis on the tumor progression and human papillomavirus association.
Chang KC; Su IJ; Tsai ST; Shieh DB; Jin YT
Oncology; 2002; 63(4):362-9. PubMed ID: 12417791
[TBL] [Abstract][Full Text] [Related]
32. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
34. "p53 mutation spectrum and its role in prognosis of oral cancer patients: A study from Gujarat, West India".
Singh RD; Patel KR; Patel PS
Mutat Res; 2016 Jan; 783():15-26. PubMed ID: 26687995
[TBL] [Abstract][Full Text] [Related]
35. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients.
Shin KH; Park KH; Hong HJ; Kim JM; Oh JE; Choung PH; Min BM
Int J Oncol; 2002 Aug; 21(2):297-302. PubMed ID: 12118324
[TBL] [Abstract][Full Text] [Related]
37. p53 immunoprofiling of potentially malignant oral disorders: a case series analysis.
Reddy VM; Kamath A; Radhakrishnan RA
Indian J Cancer; 2012; 49(1):27-32. PubMed ID: 22842165
[TBL] [Abstract][Full Text] [Related]
38. Computer-assisted analysis of p53 and PCNA expression in oral lesions infected with human papillomavirus.
Soares CP; Benatti Neto C; Fregonezi PA; Teresa DB; Santos RT; Longatto Filho A; Maeda MY
Anal Quant Cytol Histol; 2003 Feb; 25(1):19-24. PubMed ID: 12630078
[TBL] [Abstract][Full Text] [Related]
39. p53 and MDM2 expression in oral squamous cell carcinoma.
Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
[TBL] [Abstract][Full Text] [Related]
40. Mutations and polymorphisms in the p53, p21 and p16 genes in oral carcinomas of Indian betel quid chewers.
Heinzel PA; Balaram P; Bernard HU
Int J Cancer; 1996 Nov; 68(4):420-3. PubMed ID: 8945609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
